Distinct Roles for Intestinal Epithelial Cell-Specific Hdac1 and Hdac2 in the Regulation of Murine Intestinal Homeostasis

Journal of Cellular Physiology

Volumn 231, Issue 2, 2016, Pages 436-448

  Gonneaud, Alexis ^a   Turgeon, Naomie ^a   Boudreau, François ^a   Perreault, Nathalie ^a   Rivard, Nathalie ^a   Asselin, Claude ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 3; CRE RECOMBINASE; DNA; FLAVONE DERIVATIVE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; STAT3 PROTEIN; TAMOXIFEN; VILLIN; HDAC1 PROTEIN, MOUSE; HDAC2 PROTEIN, MOUSE; MTOR PROTEIN, MOUSE; NOTCH RECEPTOR; STAT3 PROTEIN, MOUSE; TARGET OF RAPAMYCIN KINASE;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DNA DAMAGE; FIBROSIS; GENE DELETION; GOBLET CELL; GRANULOCYTE; HOMEOSTASIS; INTESTINE EPITHELIUM CELL; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PANETH CELL; PHENOTYPE; PRIORITY JOURNAL; 129 MOUSE; ANIMAL; C57BL MOUSE; COLITIS; CONGENITAL MALFORMATION; CYTOLOGY; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; EPITHELIUM CELL; GENETICS; INTESTINE MUCOSA; METABOLISM; MUCOSAL IMMUNITY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLITIS; DISEASE MODELS, ANIMAL; DNA DAMAGE; EPITHELIAL CELLS; GOBLET CELLS; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HOMEOSTASIS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOR SERINE-THREONINE KINASES;

EID: 84944929580     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25090     Document Type: Article

References (63)

1. Alenghat T, Artis D. 2014. Epigenomic regulation of host-microbiota interactions. Trends Immunol 35:518-525.
2. Asselin C, Gendron FP. 2014. Shuttling of information between the mucosal and luminal environment drives intestinal homeostasis. FEBS Lett 588:4148-4157.
3. Bhaskara S. 2015. Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers. Cell Cycle 14:1779-1785.
4. Bhaskara S, Jacques V, Rusche JR, Olson EN, Cairns BR, Chandrasekharan MB. 2013. Histone deacetylases 1 and 2 maintain S-phase chromatin and DNA replication fork progression. Epigen Chromatin 6:27.
5. Boudreau F, Lussier CR, Mongrain S, Darsigny Drouin JL, Doyon G, Suh ER, Beaulieu JF, Rivard N, Perreault N. 2007. Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia. FASEB J 21:3853-3865.
6. Cantley MD, Haynes DR. 2013. Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs. Inflammopharmacol 21:301-307.
7. Choudhary C, Weinert BT, Verdin E, Mann M. 2014. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol 15:536-550.
8. Clevers HC, Bevins CL. 2013. Paneth cells: Maestros of the small intestinal crypts. Annu Rev Physiol 75:289-311.
9. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238-249.
10. Delcuve GP, Khan DH, Davie JR. 2012. Roles of histone deacetylases in epigenetic regulation: Emerging paradigms from studies with inhibitors. Clin Epigenetics 4:5.
11. El Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L, Louvard D, Chambon P, Metzger D, Robine S. 2004. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39:186-193.
12. Falkenberg KJ, Johnstone RW. 2014. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 13:673-691.
13. Fallarino F, Romani L, Puccetti P. 2014. AhR: Far more than an environmental sensor. Cell Cycle 13:2645-2646.
14. Feil S, Valtcheva N, Feil R. 2009. Inducible cre mice. Methods Mol Biol 530:343-363.
15. Felice C, Lewis A, Armuzzi A, Lindsay JO, Silver A. 2014. Review article: selective histone deacetylas isoforms as potential trerapeutc targets in inflammatory bowel diseases. Aliment Pharmacol Ther 41:26-38.
16. Fenton TR, Gwalter J, Ericsson J, Gout IT. 2010. Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo. Int J Biochem Cell Biol 42:359-366.
17. Filippakopoulos P, Knapp S. 2014. Targeting bromodomains: Epigenetic readers of lysine acetylation. Nat Rev Drug Discov 13:337-356.
18. Furumatsu K, Nishiumi S, Kawano Y, Ooi M, Yoshie T, Shiomi Y, Kutsumi H, Ashida H, Fujii-Kuriyama Y, Azuma T, Yoshida M. 2011. A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig Dis Sci 56:2532-2544.
19. Glauben R, Batra A, Stroh T, Erben U, Fedke I, Lehr HA, Leoni F, Mascagni P, Dinarello CA, Zeitz M, Siegmund B. 2008. Histone deacetylases: Novel targets for prevention of colitis-associated cancer in mice. Gut 57:613-622.
20. Glauben R, Batra A, Fedke I, Zeitz M, Lehr HA, Leoni F, Mascagni P, Fantuzzi G, Dinarello CA, Siegmund B. 2006. Histone hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol 176:5015-5022.
21. Guarani V, Deflorian G, Franco CA, Kruger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostolavsky R, Schmidt MH, Zimmermann B, Brandes RP, Mione M, Westphal CH, Braun T, Zeiher AM, Gerhardt H, Dimmeler S, Potente M. 2012. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 473:234-238.
22. Hagelkruys A, Lagger S, Krahmer J, Leopoldi A, Artaker M, Pusch O, Zexula J, Weissmann S, Xie Y, Schöfer C, Schlederer M, Brosch G, Matthias P, Selfridge J, Lassmann H, Knoblich JA, Seiser C. 2014. A single allele of Hdac2 but not Hdac1 is sufficient for normal brain development in the absence of its paralog. Development 141:604-616.
23. Hao N, Whitelaw ML. 2013. The emerging roles of AhR in physiology and immunity. Biochem Pharmacol 86:561-570.
24. Hong S, Zhao B, Lombard DB, Fingar DC, Inoki K. 2014. Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signalling in the regulation of S6 kinase 1 (S6K1) phosphorylation. J Biol Chem 289:13132-13141.
25. Ireland H, Kemp R, Houghton C, Howard L, Clarke AR, Sansom OJ, Winton DJ. 2004. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: Effect of loss of β-catenin. Gastroenterology 126:1236-1246.
26. Ivashkevich A, Redon CE, Nakamura AJ, Martin RF, Martin OA. 2012. Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett 327:123-133.
27. Johannson ME, Sjövall H, Hansson GC. 2013. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 10:352-361.
28. Kelly RD, Cowley SM. 2013. The physiological roles of histone deacetylase (HDAC) 1 and 2: Complex co-stars with multiple leading parts. Biochem Soc Trans 41:406-412.
29. Khor B, Gardet A, Xavier RJ. 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature 474:307-317.
30. Kizil C, Kyritsis N, Brand M. 2015. Effects of inflammation on stem cells: Together they strive? EMBO Rep 16:416-426.
31. Labrecque MP, Prefontaine GG, Beischlag TV. 2013. The aryl hydrocarbon receptor nuclear translocator (ARNT) family of proteins: Transcriptional modifiers with multi-functional protein interfaces. Curr Mol Med 13:1047-1065.
32. Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, Schuettengruber B, Hauser C, Brunmeir R, Jenuwein T, Seiser C. 2002. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21:2672-2681.
33. Laplante M, Sabatini DM. 2012. MTOR signalling in growth control and disease. Cell 13:274-293.
34. Laugesen A, Helin K. 2014. Chromatin repressive complexes in stem cells, development, and cancer. Cell Stem Cell 14:735-751.
35. LeBoeuf M, Terrell A, Trivedi S, Sinha S, Epstein JA, Olson EN, Morrisey EE, Millar SE. 2010. Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev Cell 19:807-818.
36. Ma J, Meng Y, Kwiatkowski DJ, Chen X, Peng H, Sun Q, Zha X, Wang F, Wang Y, Jing Y, Zhang S, Chen R, Wang L, Wu E, Cai G, Malinowska-Kolodziej I, Liao Q, Liu Y, Zhao Y, Sun Q, Xu K, Dai J, Han J, Wu L, Zhao RC, Shen H, Zhang H. 2010. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J Clin Invest 120:103-114.
37. Madison BB, Dunbar L, Qiao XT, Braunstein K, Braunstein E, Gumucio DL. 2002. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem 277:33275-33283.
38. Maloy KJ, Powrie F. 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474:298-306.
39. Miller KM, Tjeertes JV, Coates J, Legube G, Polo SE, Britton S, Jackson SP. 2010. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol 17:1144-1151.
40. Monteleone I, Pallone F, Monteleone G. 2013. Aryl hydrocarbon receptor and colitis. Semin Immunopathol 35:671-675.
41. Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, Olson EN. 2007. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21:1790-1802.
42. Moser MA, Hagelkruys A, Seiser C. 2014. Transcription and beyond: The role of mammalian class I lysine deacetylases. Chromosoma 123:67-78.
43. Neufert C, Pickert G, Zheng Y, Wittkopf N, Warntjen M, Nikolaev A, Ouyang W, Neurath MF, Becker C. 2010. Activation of STAT3 regulates intestinal homeostasis. Cell Cycle 9:652-655.
44. Newman JC, Verdin E. 2014. β-hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract 106:173-181.
45. Noah TK, Shroyer NF. 2013. Notch in the intestine: Regulation of homeostasis and pathogenesis. Annu Rev Physiol 75:263-288.
46. Okamoto R, Tsuchiya K, Nemoto Y, Akiyama J, Nakamura T, Kanai T, Watanabe M. 2009. Requirement of Notch activation during regeneration of the intestinal epithelia. Am J Physiol 296:G23-G35.
47. Palermo R, Checquolo S, Giovenco A, Grazioli P, Kumar V, Campese AF, Giorgi A, Napolitano M, Canettieri G, Ferrara G, Schinina ME, Maroder M, Frati L, Gulino A, Vacca A, Screpanti I. 2012. Acetylation controls Notch3 stability and function in T-cell leukemia. Oncogene 31:3807-3817.
48. Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH. 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 8:80-93.
49. Peterson LW, Artis D. 2014. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nat Rev Immunol 14:141-153.
50. Redon CE, Weyemi U, Parekh PR, Huang D, Burrell AS, Bonner WM. 2012. γ-H2AX and other histone post-translational modifications in the clinic. Biochim Biophys Acta 1819:743-756.
51. Robert T, Vanoli F, Chiolo I, Shubassi G, Bernstein KA, Rothstein R, Botrugno OA, Parazzoli D, Oldani A, Minucci S, Foiani M. 2011. HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature 471:74-79.
52. Sancho R, Cremona CA, Behrens A. 2015. Stem cell and progenitor fate in the mammalian intestine: Notch and lateral inhibition in homeostasis and disease. EMBO Rep 16:571-581.
53. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV, de Cabo R, Ulrich S, Akassoglou K, Verdin E. 2013. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339:211-214.
54. Singh NP, Singh UP, Singh B, Price RL, Nagarkatti M, Nagarkatti PS. 2011. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS ONE 8:e23522.
55. Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, Li B, Turka LA, Olson EN, Greene MI, Wells AD, Hancock WW. 2007. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13:1299-1307.
56. Tetteh PW, Farin HF, Clevers H. 2015. Plasticity within stem cell hierarchies in mammalian epithelia. Trends Cell Biol 25:100-108.
57. Turgeon N, Blais M, Gagné JM, Tardif V, Boudreau F, Perreault N, Asselin C. 2013. HDAC1 and HDAC2 restrain the intestinal inflammatory response by regulating intestinal epithelial cell differentiation. PLoS ONE 8:e73785.
58. Turgeon N, Moore Gagne J, Blais M, Gendron FP, Boudreau FD, Asselin C. 2014. The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis. Am J Physiol 306:G594-G605.
59. Winter M, Moser MA, Meunier D, Fischer C, Machat G, Mattes K, Lichtenberger BM, Brunmeir R, Weissmann S, Murko C, Humer C, Meischel T, Brosch G, Matthias P, Sibilia M, Seiser C. 2013. Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis. EMBO J 32:3176-3191.
60. Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C, Matthias P. 2010. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev 24:455-469.
61. Zhou Y, Rychahou P, Wang Q, Weiss HL, Evers BM. 2015. TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium. Cell Death Dis 6:e1631. doi: 10.1038/cddis.2014.588
62. Zhou Y, Wang Q, Weiss HL, Evers BM. 2014. Nuclear factor of activated T-cells 5 increases intestinal goblet cell differentiation through an mTOR/Notch signalling pathway. Mol Cell Biol 25:2882-2890.
63. Zimberlin CD, Lancini C, Sno R, Rosekrans SL, McLean CM, Vlaming H, van der Brink GR, Bots M, Medema JP, Danneberg JH. 2015. HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis. FASEB J 29:2070-2080.